MGMT and glioblastoma: Currently, there is an ongoing open-label, multi-center, phase 1 study (ClinicalTrials.gov ID NCT05432375) of TINO, used as an adjuvant treatment in patients with newly diagnosed glioblastoma who are MGMT unmethylated and have completed concomitant treatment with TMZ and radiation.